Researchers offer a framework for clinicians to assess and predict the outcomes in patients with myasthenia gravis (MG), particularly when encountering them for the first time. It reviews several factors critical for prognosis: clinical type, age at onset, antibody status, disease severity, thymus pathology, autoimmune presence, and other comorbid conditions. These factors are essential to understanding the likely progression and outcomes of MG in individual patients.
Reference: Almodovar JL, Mehrabyan A. Disease-Based Prognostication: Myasthenia Gravis. Semin Neurol. 2023 Oct;43(5):799-806. doi: 10.1055/s-0043-1775791. Epub 2023 Sep 26. PMID: 37751854.
